These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25879366)

  • 1. Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
    Zhang Q; Wang J; Zhang H; Zhao D; Zhang Z; Zhang S
    J Cancer Res Ther; 2015; 11(1):223-8. PubMed ID: 25879366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of aminopeptidase N in non-small cell lung cancer.
    Tokuhara T; Hattori N; Ishida H; Hirai T; Higashiyama M; Kodama K; Miyake M
    Clin Cancer Res; 2006 Jul; 12(13):3971-8. PubMed ID: 16818694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma.
    Kawamura J; Shimada Y; Kitaichi H; Komoto I; Hashimoto Y; Kaganoi J; Miyake M; Yamasaki S; Kondo K; Imamura M
    Hepatogastroenterology; 2007; 54(73):36-40. PubMed ID: 17419227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
    Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
    PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients.
    Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI
    Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating aminopeptidase N/CD13 is an independent prognostic factor in patients with non-small cell lung cancer.
    Murakami H; Yokoyama A; Kondo K; Nakanishi S; Kohno N; Miyake M
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8674-9. PubMed ID: 16361553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and clinical significance of MAPK in non-small cell lung cancer].
    Zhang ZF; Ma JQ; Zhang L
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):339-42. PubMed ID: 15854513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-153 expression and prognosis in non-small cell lung cancer.
    Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW
    Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
    Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
    Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
    Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of protein-tyrosine-phosphatase 1B in non-small-cell lung cancer and its prognostic significance].
    Wang ZF; Liu HB; Yao YW; Chen FF; Song Y
    Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(38):3027-30. PubMed ID: 24417921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T
    Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between RGS5 expression and cancer differentiation and metastasis in non-small cell lung cancer.
    Huang G; Song H; Wang R; Han X; Chen L
    J Surg Oncol; 2012 Mar; 105(4):420-4. PubMed ID: 21780128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of prognostic factors in 1826 patients with completely resected non-small cell lung cancer].
    Gao YS; Xing XZ; Shao K; Feng XL; He J
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):134-7. PubMed ID: 18646698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.